Tomasz Ślebioda

The Death Receptor 3–TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis

Melanie Bull, Anwen S. Williams, Zarabeth Mecklenburgh et al. · The Journal of Experimental Medicine · 2008 · 113 citations · Full text

Medicine, Immunology, Pathobiology +17

Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia

Vadim Y. Taraban, Tomasz Ślebioda, Jane E. Willoughby et al. · Mucosal Immunology · 2010 · 95 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Triggering of TNFRSF25 promotes CD8⁺ T‐cell responses and anti‐tumor immunity

Tomasz Ślebioda, Tania F. Rowley, John R. Ferdinand et al. · European Journal of Immunology · 2011 · 60 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

Vitamin D derivatives enhance cytotoxic effects of H2O2 or cisplatin on human keratinocytes

Anna Piotrowska, Justyna Wierzbicka, Tomasz Ślebioda et al. · Steroids · 2016 · 47 citations · Full text

Medicine, Dermatology, Toxicology +12

Evaluation of peripheral blood T lymphocyte surface activation markers and transcription factors in patients with early stage non-small cell lung cancer

Jacek Rutkowski, Marta Cyman, Tomasz Ślebioda et al. · Cellular Immunology · 2017 · 29 citations

Life Sciences, Immunology, Oncology +16